Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis

Electrophoresis

Volumn 30, Issue 7, 2009, Pages 1119-1131

  Dai, Lan ^a   Li, Chen ^b   Shedden, Kerby A ^b   Misek, David E ^a   Lubman, David M ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

cIEF; Ovarian cancer; Pathway analysis; Proteins; Quantitation

Indexed keywords

CELL CULTURE; CELL SIGNALING; CELLS; MASS SPECTROMETERS; MASS SPECTROMETRY; MOLECULAR BIOLOGY;

ADENOCARCINOMA CELLS; CELL LINES; CIEF; COMPARATIVE PROTEOMICS; ENDOMETRIOID ADENOCARCINOMA; OVARIAN CANCERS; PATHWAY ANALYSIS; PROTEOMIC STUDIES; QUANTITATION; SIGNALLING PATHWAYS;

PEPTIDES;

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53;

ARTICLE; BIOINFORMATICS; CAPILLARY ISOELECTRIC FOCUSING; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 65949089022     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.200800505     Document Type: Article

References (26)

1. McCluskey, L. L., Dubeau, L., Curr. Opin. Oncol. 1997, 9, 465-470.
2. Scully, R. E., Young, R. H., Clement, P. B., Atlas of Tumor Pathology, Third Series, Fascicle 23, AFIP, Washington, DC 1998.
3. Freedman, R. S., Pihl, E., Kusyk, C., Gallager, H. S., Rutledge, F., Cancer 1978, 42, 2352-2359.
4. Provencher, D.M., Lounis, H., Champoux, L., Tetrault,M., Manderson, E. N., Wang, J. C., Eydoux, P., In Vitro Cell Dev. Biol. Anim. 2000, 36, 357-361.
5. Wu, R., Zhai, Y., Fearon, E. R., Cho, K. R. Cancer Res. 2001, 61, 8247-8255
6. Wang, J. H., Hewick, R. M. Drug Discov. Today 1999, 4, 129-133.
7. Wang, H., Kachman, M. T., Schwartz, D. R., Cho, K. R., Lubman, D. M. Proteomics 2004, 4, 2476-2495.
8. Gagne, J. P., Gagne, P., Hunter, J. M., Bonicalzi, M. E., Mol. Cell. Biochemistry 2005, 275, 25-55.
9. Washburn, M. P., Wolters, D., Yates, J. R., Nat. Biotechnol. 2001, 19: 242-247.
10. Wang, Y., Balgley, B. M., Rudnick, P. A., Evans, E. L., J. Proteome Res. 2005. 4, 36-42.
11. Zhou, F., Johnston, M. V., Electrophoresis 2005, 26, 1383-1388.
12. Andreev, V. P., Li, L., Cao, L., Gu, Y., J. Proteome Res. 2007, 6, 2186-2194.
13. Wong, J. W. H., Sullivan, M. J., Cagney, G., Brief. Bioinform. 2008, 9, 156-165.
14. Liu, H., Sadygov, R. G., Yates, J. R., Anal. Chem. 2004, 76, 4193-4201.
15. Silvia, M., Uriarte, D. W., Powell, G. C., Luerman, M. L., J. Immunol. 2008. 180, 5575-5581.
16. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Anal. Chem. 2002, 74, 5383-5392.
17. Curmi, P. A., Nogues, C., Lachkar, S., Carelle, N., Br. J. Cancer 2000, 82, 142-150.
18. Nishio, K., Nakamura, T., Koh, Y., Kanzawa, F., Cancer 2001, 91, 1494-1499.
19. Chen, Z., Cancer 2001, 92, 3068-3075.
20. Jacobberger, J. W., Sramkoski, R. M., Zhang, D. S., Zumstein, L.A., Cytometry 1999, 38, 201-213.
21. Conroy, S. E., Latchman, D. S., Br. J. Cancer 1996, 74, 717-721
22. Tonin, P. N., Hudson, T. J., Rodier, F., Bossolasco, M., Oncogene 2001, 20, 6617-6626.
23. Jones, M. B., Krutzsch, H., Shu, H., Zhao, Y., Proteomics 2002, 2, 76-84.
24. Alaiya, A. A., Franzen, B., Fujioka, K., Moberger, B. Int. J. Cancer 1997, 73, 678-683.
25. Campbell, I. G., Russell, S. E., Choong, D. Y., Montgomery, K. G. Cancer Res. 2004, 64, 7678-7681.
26. Nicosia, S. V., Bai, W., Cengu, J. Q., Coppola, D. Hematol. Oncol. Clin. North Am. 2003, 17, 927-943.